You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-Cytokeratin 5 antibody [EP1601Y] (ab52635)

CodeSizePriceAbpointsAvailability
    
Add to basket
 

  • -

  •   
  •   
  •   

  •  

  •  
  •  

  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab52635? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab52635 has been referenced in 3 publications.

  1. Volkmer JP et al. Three differentiation states risk-stratify bladder cancer into distinct subtypes. Proc Natl Acad Sci U S A 109:2078-83 (2012). IHC-P; Human. PubMed: 22308455
  2. Tokar EJ et al. Arsenic-specific stem cell selection during malignant transformation. J Natl Cancer Inst 102:638-49 (2010). ICC/IF; Human. PubMed: 20339138
  3. Sun Y et al. Aberrant cytokeratin expression during arsenic-induced acquired malignant phenotype in human HaCaT keratinocytes consistent with epidermal carcinogenesis. Toxicology 262:162-70 (2009). PubMed: 19524636

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"